Decision Diagnostics Stock Today
| DECN Stock | USD 0.0001 0.00 0.00% |
Performance0 of 100
| Odds Of DistressOver 85
|
Decision Diagnostics is selling at 1.0E-4 as of the 26th of November 2024; that is No Change since the beginning of the trading day. The stock's open price was 1.0E-4. Decision Diagnostics has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Decision Diagnostics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of October 2024 and ending today, the 26th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | Category Healthcare | Classification Health Care |
Decision Diagnostics Corp. develops smart phone based electronic medical record technologies. Decision Diagnostics Corp. was founded in 2000 and is based in Westlake Village, California. Decision Diagnostics operates under Pharmaceutical Retailers classification in the United States and is traded on OTC Exchange. The company has 357.87 M outstanding shares. More on Decision Diagnostics
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Decision Stock Highlights
| CEO | Keith Berman | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Technology, Health Care Equipment & Services, Health Care, Health Care, Health Care Technology, Pharmaceutical Retailers, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsDecision Diagnostics can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Decision Diagnostics' financial leverage. It provides some insight into what part of Decision Diagnostics' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Decision Diagnostics (DECN) is traded on OTCCE Exchange in USA and employs 6 people. Decision Diagnostics is listed under Health Care Technology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 35.79 K. Decision Diagnostics conducts business under Health Care Technology sector and is part of Health Care industry. The entity has 357.87 M outstanding shares.
Decision Diagnostics currently holds about 210.85 K in cash with (1.4 M) of positive cash flow from operations.
Check Decision Diagnostics Probability Of Bankruptcy
Decision Stock Against Markets
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Decision Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Decision Diagnostics. If investors know Decision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Decision Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.02) | Revenue Per Share 0.006 | Quarterly Revenue Growth (0) | Return On Assets (0.21) | Return On Equity (81.61) |
The market value of Decision Diagnostics is measured differently than its book value, which is the value of Decision that is recorded on the company's balance sheet. Investors also form their own opinion of Decision Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Decision Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Decision Diagnostics' market value can be influenced by many factors that don't directly affect Decision Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Decision Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Decision Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Decision Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.